PROADM AS MARKER INDICATING AN ADVERSE EVENT Application EP-4220175-A1 European Patent Office 02 Aug 2023
PRO-ADM FOR THERAPY MONITORING OF INTENSIVE CARE UNIT PATIENTS Application EP-4027145-A1 European Patent Office 13 Jul 2022
PROADRENOMEDULLIN AS A MARKER FOR ABNORMAL PLATELET LEVELS Application EP-3971573-A1 European Patent Office 23 Mar 2022
PROADRENOMEDULLIN AS A MARKER FOR ABNORMAL PLATELET LEVELS Application EP-3971572-A1 European Patent Office 23 Mar 2022